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I.  INTRODUCTION 
Over the past few years, the stem cell debate has grown heated, becoming one of 
the most controversial topics addressed in the United States today.  However, the 
current debate, centering primarily on embryonic stem cells, neglects to recognize 
and address the significance of a different type of stem cell that is less controversial 
and is already being used to treat and cure a variety of diseases.1  Stem cells located 
in the blood of the umbilical cord of a newly delivered infant can be easily and 
painlessly harvested from the cord2 and then donated by the mother to a public or 
private bank for future use in treating the diseases of matching recipients.3  More 
specifically, cord blood stem cells can be transplanted into individuals suffering from 
certain cancers or blood disorders as a way to treat and cure their condition.4  
                                                                
1Courtney Witte, Commentary, Cord Blood Storage Property and Liability Issues, 26 J. 
LEGAL MED. 275, 277 (2005).  “The California Catholic Conference states that cord blood is a 
non-controversial and ethical supply of stem cells…[that] provides a more effective transplant 
source than bone marrow at one third the cost.” Dale Orthner, Chapter 484: Informing 
Expectant Mothers About Umbilical Cord Blood Banking, 38 MCGEORGE L. REV. 205, 212 
(2007). 
2Witte, supra note 1, at 276-77. 
3Orthner, supra note 1, at 206. 
4Joanne Kurtzberg et al., Untying the Gordian Knot: Policies, Practices, and Ethical 
Issues Related to Banking of Umbilical Cord Blood, 115 J. CLIN. INVEST. 2592, 2593, 2596 
(2005).  
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Although these stem cells have significant medical potential, lack of awareness 
of donation and failure to provide donation services result in missed donation 
opportunities.5  While there is legislation at both the federal and state levels 
encouraging information to be provided to expecting mothers as a means to increase 
donation, such legislation falls below that necessary to truly promote and increase 
donations.6  Current legislation, including Ohio’s proposed legislation, Ohio House 
Bill 237 (“OH H.B. 237”) tends to encourage, rather than require, that information 
about cord blood donation be provided, and there is no requirement that donation 
services be made available to each patient.7  Because there are no assurances that 
information and donation services will actually be provided to pregnant women, the 
legislation cannot realistically improve the number of donations.   
Because current legislation, including OH H.B. 237, is insufficient in that it does 
not have the potential to significantly increase the number of cord blood donations, it 
will be necessary to enact legislation that is more demanding.  Such legislation 
should be modeled after current “required request” organ donation laws, which 
mandate that health professionals actively pursue organ donations by expressly 
asking the family to consent to donation.8  Modeled after these laws, better 
legislation will not only require that state health departments generate information 
about donation opportunities, but also that health professionals then provide each 
maternity patient with materials about cord blood donation and, if desired, donation 
services.  
This note will discuss the use and donation of umbilical cord blood stem cells 
and explore the insufficiency of current legislation intended to promote public 
donation.  Part II will provide an explanation of stem cells and umbilical cord blood 
stem cells and will discuss the specific use of umbilical cord blood stem cells to treat 
different diseases.  Part III will discuss the collection and storage of umbilical cord 
blood stem cells.  Part IV will address the history of cord blood transplants and the 
current demand for donations.  Part V will discuss the current proposed and enacted 
legislation regarding umbilical cord blood stem cell awareness and donation at the 
federal and state levels.  Part VI will discuss OH H.B. 237, explaining both the 
content of the proposed legislation and its shortcomings.  Part VII will focus on 
current organ donation laws, detailing the transition in the United States from 
encouraged voluntarism to routine inquiry and required request.  Finally, Part VIII 
will detail a more appropriate, sufficient piece of legislation, modeled after the 
required request laws, which Ohio should adopt in lieu of OH H.B. 237. 
                                                                
5Orthner, supra note 1, at 212. 
6See, e.g., CAL. HEALTH & SAFETY CODE §123371 (West 2008), amended by 2007 Cal. 
Legis. Serv. Ch. 517 (S.B. 962) (West) (explaining that information about the option to donate 
umbilical cord blood be generated, but not requiring that the information be provided to each 
pregnant patient).  While Congress has allocated funds to create a national cord blood stem 
cell bank network, little has been done to raise awareness.  As a result, pregnant women are 
often unaware of the option to donate their infant’s umbilical cord blood to either a public or 
private bank.  Caroline P. Torrisi, Embryonic vs. Adult: The History and Future of the Stem 
Cell Debate, 3 J. HEALTH & BIOMED. L. 143, 161 (2007). 
7H.B. 237, 127th Gen. Assembl., Reg. Sess. (Ohio 2007). 
8Melissa N. Kurnit, Organ Donation in the United States: Can We Learn From Success 
Abroad? 17 B.C. INT’L & COMP. L. REV. 405,  412 (1994).   
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II.  STEM CELLS 
Stem cells are cells within the human body that have the potential to develop into 
many different cell types.9  Because stem cells have the ability to develop into other 
types of cells, they are able to serve as a sort of repair system for the body, 
developing without limit to replenish other cells that have been damaged or no 
longer function as a result of disease.10  Scientists can work with stem cells in the lab 
and engineer them to become a specific type of tissue, cell, or organ to be used in 
transplantation or treatment of specific diseases.11  
Human stem cells can be totipotent, pluripotent, or multipotent.12  Totipotent 
cells give rise to all the different types of cells in the body and therefore have the 
potential to develop into a fully formed human being.13  Totipotent cells, which are 
found in fertilized human eggs, “are created at fertilization and are present for four 
days immediately following conception, after which they become pluripotent 
cells.”14  Pluripotent cells are able to give rise to any type of cell in the body except 
those needed to develop a fetus, and are found in human embryos and fetal tissue.15   
Multipotent stem cells are only able to give rise to a smaller, limited number of 
different cell types.16  Because totipotent and pluripotent stem cells have the potential 
to develop into a greater number of different cell types, they have greater therapeutic 
potential.17   More specifically, pluripotent stem cells may have the potential to 
create replacement cells and tissues to treat diseases and conditions including 
                                                                
9The National Institute of Health, Stem Cell Information: Frequently Asked Questions, 
http://stemcells.nih.gov/info/faqs.asp (last visited November 18, 2007) [hereinafter NIH].  All 
stem cells have the ability to divide and renew themselves indefinitely.  Torrisi, supra note 6, 
at 144.  Although they are unspecialized, meaning that they do not belong to any specific 
tissue structure that would cause them to form a specialized function, they can, through 
differentiation, develop into specialized cells.  Id.  
10NIH, supra note 9.  
11Id.  
12Torrisi, supra note 6, at 144.  
13Id. Because they have the potential to develop into a fully formed human being, the use 
of totipotent cells, like pluripotent cells, has met with strong ethical objections. Id.  
14Id.  
15NIH, supra note 9.  
16Id. Multipotent cells can only develop into cells with the same tissue or organ.  So, for 
example, multipotent blood cells are only able to develop into other types of blood cells, and 
cannot, therefore, develop into brain cells.  Torrisi, supra note 6, at 145. 
17NIH, supra note 9.  “Plasticity” is a term used to refer to a cell’s ability to develop into 
more than one type of cell.  Pluripotent stem cells, like those extracted from embryos, have a 
higher plasticity than multipotent adult stem cells.  In addition to having greater plasticity, 
pluripotent embryonic stem cells multiply at a faster rate than multipotent adult stem cells.  
Rebekah L. Bailey, Pressing Forward: Connecticut’s Approach to Embryonic Stem Cell 
Research, 26 L. & INEQ. 133, 138 (2008).  
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Parkinson’s and Alzheimer’s diseases, spinal cord injury, stroke, burns, heart 
disease, diabetes, osteoarthritis, and rheumatoid arthritis.18  
Embryonic stem cells, which are pluripotent stem cells extracted from human 
embryos, “are derived from a cluster of cells called the inner cell mass of the 
blastocyst, located within a fertilized egg.”19  The cluster of cells from which the 
stem cells are taken exist only throughout the first few days of development.20  If the 
cells are extracted within those first few days before the cells begin to differentiate, 
they can be kept as undifferentiated stem cells, retaining their potential to develop 
into any type of cell.21  However, because removing the cluster of cells from the 
blastocyst destroys the embryo, widespread ethical concerns over the use and 
destruction of human embryos arises.22   
                                                                
18NIH, supra note 9.  Because embryonic stem cells have the potential to cure such a wide 
variety of diseases afflicting numerous Americans, many scientists, academics, politicians, and 
other well known individuals have joined in the heated debate, publicly announcing their 
support for embryonic stem cell research.  Actor Michael J. Fox, for example, has become a 
public advocate for embryonic stem cell research, explaining, “[t]his is big.  This is not a 
wedge issue…This is…who we are as a country and how we feel about our people and about 
the majority…respecting the minority.  If the potential of stem cell research is realized, it 
would mean an end to the suffering of millions of people—a rescue, a cure…Stem cells could 
lead to breakthroughs in developing treatments and cures for almost any terminal or 
catastrophic disease you can think of.  This is one of the reasons that support for this work has 
galvanized a coalition of advocates from just about every patient community in the nation.  If 
stem cell research succeeds, there isn’t a person in the country who won’t benefit, or know 
somebody who will.”  Bailey, supra note 17, at 133.  Professor Cibelli, head of the Cellular 
Reprogramming Laboratory at Michigan State University, has echoed some of these 
sentiments, exclaiming, “[W]ake up America!  This is not about Republican vs. Democrat, 
pro-life vs. pro-choice, scientists vs. intellectuals, embryonic stem cells vs. adult stem cells.  It 
is about compassion for those suffering.  It is about millions of patients around the world that 
deserve better quality of life.” Id. at 169.  
19Torrisi, supra note 6, at 145.  Stem cells were first successfully isolated from mouse 
embryos in 1981.  In 1998, two different groups of scientists were able to isolate human 
embryonic stem cells.  Dr. John Gearhart of Johns Hopkins University, along with his team of 
researchers, extracted embryonic germ cells from an aborted fetus.  Dr. James Thompson of 
the University of Wisconsin-Madison, along with his research team, extracted stem cells from 
an embryo obtained from an in vitro fertilization clinic.  Bailey, supra note 17, at 135-36.  
20Torrisi, supra note 6, at 145.  
21Id. at 146.  If the blastocyst successfully attaches to the uterus, it will begin to multiply 
and differentiate, eventually forming a human fetus, placenta, and umbilical cord.  However, 
about seventy-five percent of blastocysts never attach to become fetuses.  In some instances 
more than one blastocyst will attach, which could cause multiple fetuses, but it is also likely 
that some of the attached blastocysts will be dissolved or subsumed into the surviving embryo.  
Bailey, supra note 17, at 136.  
22Torrisi, supra note 6, at 143.  Not all of the cells in the blastocyst continue to form a 
fetus; some will develop into the placenta or umbilical cord.  As a result, some scientists prefer 
to label the cells of the blastocyst at this point in development as “preimplantation” embryos 
or “prembryos.”  Bailey, supra note 17, at 136. 
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Federal funding for the use and development of embryonic stem cells is limited23 
as a result of these ethical concerns.24  Throughout the 1980’s, both former 
Presidents Reagan and Bush Sr. strongly opposed embryonic stem cell research.25  
Former President Clinton, however, was supportive, and after his election in 1994 he 
lifted the long-standing ban on federal funding of embryonic stem cell research.26  
The National Institute of Health (“NIH”), however, was still unable to gain the 
approval of Congress for federal funding of embryonic stem cell research.27  In 2000 
the NIH Guidelines were released, which encouraged federal funding for research 
done on embryonic stem cells that were originally created for the purposes of fertility 
treatment,28 but rejected federal funding for research done on cells created solely for 
research purposes.29  However, President Bush rejected these guidelines in 2001 
                                                                
23Torrisi, supra note 6, at 160. 
24See generally Bailey, supra note 17, at 140.  Bailey points out that opponents of 
embryonic stem cell research have analogized the destruction of embryos in the research to 
abortion.  Bailey suggests that this analogy is inappropriate, however, and that the effect of the 
pro-life movement on embryonic stem cell research is tragic because of the selectivity of 
prohibition against embryonic and fetal destruction.  She explains that while opponents 
analogize stem cell research to the termination of developed fetuses, embryonic stem cell 
research laws are rarely applied to alternative reproduction technologies, and points out that, 
although in vitro fertilization involves the destruction of embryos at a similar stage of 
development as done with embryonic stem cells, in vitro fertilization practices enjoy much 
more limited restrictions than stem cell research.  
25Id. at 156.  
26Id.  Former President Clinton continued to endorse his position, giving a speech in 2000 
that advocated embryonic stem cell research.  In the speech Clinton stated, “[W]e cannot walk 
away from the potential to save lives and to improve lives, to help people literally to get up 
and walk, to do all kinds of things we could never have imagined, as long as we meet rigorous 
ethical standards.”  Bailey, supra note 17, at 145-46.  
27Torrisi, supra note 6, at 156.  
28Id. at 157.  In vitro fertilization treatments, which were developed in the late 1970’s, 
entail the creation of an embryo by joining a sperm and egg in the laboratory, which is then 
inserted into the woman’s womb with hopes of causing impregnation.  Bailey, supra note 17, 
at 140.  Because the chances of implantation using in vitro fertilization techniques are low, 
several embryos are injected with each treatment, and often many more embryos are created 
than are needed or will actually be used.  Id. at 140-41.  There are several options regarding 
what to do with the excess embryos.  Id. at 141.  The embryos can be destroyed, donated to 
other couples, donated to research, or suspended in cryopreservation, that is, frozen so that the 
cells do not continue to multiply.  Id.  Cryopreservation is done either to save the embryos for 
future use or to halt cell growth until a final decision is made.  Id.  
29Torrisi, supra note 6, at 157-58.  The guidelines state that in order to receive federal 
funding for embryonic stem cell research, the cells used must have come from a fertility clinic, 
the cells must be in excess of clinical need, there must have been a clear separation between 
the decision to create the embryos for fertility treatment and the decision to donate them for 
research, the cells must have been obtained with the informed consent of the fertility patient, 
and there must have been no inducement offered to the patient for the donation of the 
embryos.  Bailey, supra note 17, at 145. 
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when he announced his decision on federal funding for embryonic stem cell 
research.30  
President Bush’s policy allows federal funding for research on cell lines that have 
already been developed from embryonic stem cells, but does not allow funding for 
the creation of additional cell lines.31  More specifically, the policy limits funding to 
stem cells that were removed from the embryo before August 9, 2001, the date on 
which the President outlined the policy.32  Furthermore, the embryo must have been 
created for reproductive purposes but no longer needed, and the embryo itself must 
no longer have the possibility of developing into a human being.33  “Because many 
academic researchers rely on federal funds to support their laboratories,” such a 
limitation on research funding results in tremendous focus on embryonic stem cell 
research.34  
                                                                
30Torrisi, supra note 6, at 158.  In addition to the federal policy, some states have chosen 
to enact even more stringent limitations on embryonic stem cell research.  For example, 
Louisiana has enacted a statute which defines an embryo as a “judicial person” deserving of 
human rights until it is implanted in the uterus or fails to develop outside of cryopreservation 
within thirty-six hours.  The statute declares that the use of an embryo in in vitro fertilization 
is to be “solely for the support and contribution of the complete development of human in 
utero implantation.”  Thus, unwanted frozen embryos are only available for adoption by other 
couples, and cannot be used for research purposes.  While Louisiana has the most restrictive 
statute, other states have adopted similar legislation prohibiting embryonic stem cell research 
and attributing some level of life to human embryos.  On the other hand, other states have 
specifically endorsed embryonic stem cell research, proposing the allocation and disbursement 
of state funds for embryonic experimentation and research.  For example, Maryland, in 2007, 
began disbursing fifteen million dollars in state funding to stem cell research, while New York 
planned on disbursing two billion dollars over the course of ten years.  Connecticut enacted 
legislation in June 2005 which allocated one hundred million dollars of state funds over ten 
years to stem cell research and also created state regulations for both privately and publicly 
funded experimentation.  California adopted legislation in 2002 that declared stem cell 
research a state constitutional right, allocating three billion dollars over ten years to research, 
giving priority to embryonic stem cell research.  Other states have allowed funding for the 
construction of experimentation and research facilities, but stop short of providing funds for 
embryonic stem cell research itself.  For example, New Jersey recently considered providing 
two hundred million dollars of state funding to the construction of three new research 
facilities.  Illinois has decided to allocate ten million dollars to establish facilities and 
Wisconsin has developed similar plans as well.  Bailey, supra note 17, at 150-53.  
31Torrisi, supra note 6, at 159.  By allowing research to be done on already existing stem 
cell lines, but refusing to allow the creation of additional lines, President Bush’s policy was 
meant to be a compromise.   Id. at 157-59.  
32NIH, supra note 9. 
33Id.  President Bush’s policy also denies funding for facilities or equipment that would be 
used to conduct unauthorized embryonic stem cell research. Bailey, supra note 17, at 146. 
34NIH, supra note 9.  Because the federal regulations apply only to publicly funded 
clinics, privately funded laboratories are still able to conduct research on embryonic stem 
cells.  Torrisi, supra note 6, at 160.  Private endowments at universities including Stanford, the 
University of Wisconsin-Madison, the University of Minnesota, the University of California, 
San Francisco, and Harvard have been established to support embryonic stem cell research.  
However, generous private sources cannot adequately substitute for federal grants because of 
the substantial cost of research. Bailey, supra note 17, at 146.  Consequently, the inability of 
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When President Bush’s policy was announced in 2001, there were approximately 
60 stem cell lines already in existence that met the federally mandated criteria and 
were available for research.35  Since then, many of these lines have been damaged or 
have died, and as of March 2007, there were only 21 available lines,36 leaving 
scientists limited to an even smaller number of cell lines.37  To alleviate this problem, 
Congress passed The Stem Cell Research Enhancement Act of 2005, which allows 
federal funding for research done on stem cells harvested from surplus embryos 
created in fertility clinics.38  Even though most of the surplus cells would be 
discarded if not used for research, President Bush vetoed the legislation, stating that 
he would not force taxpayers to “fund the deliberate destruction of human 
embryos.”39  The House of Representatives passed the legislation again in 2007, but 
did not have enough votes to overcome the President’s promised veto.40 
Although embryonic stem cells have great medical potential, by focusing solely 
on embryonic stem cells, the current debate neglects a highly significant source of 
similarly valuable, but different, stem cells.41  Certain types of multipotent blood-
                                                          
publicly funded clinics to contribute to embryonic stem cell research prevents the research as a 
whole from reaching its full potential.  Torrisi, supra note 6, at 160.  See also Bailey, supra 
note 17, at 134 (stating that the federal policy “has severely hindered the progress of American 
scientists, dashing the hopes of millions who await cures for their debilitating diseases and 
injuries”).  
35Torrisi, supra note 6, at 158.  
36See Bailey, supra note 17, at 149 (arguing that the number of available cell lines seems 
insignificant when considering the fact that, as of 2003, there were 400,000 unused frozen 
embryos within the United States).  
37Scientists have discovered a problem regarding the existing cell lines, which further 
hampers embryonic stem cell research.  Mouse feeder cells excrete certain chemicals that keep 
the cells from differentiating and have been used on the existing cell lines as a way to maintain 
them for future use.   However, because use of mouse feeder cells on the cell lines may leave 
the stem cells vulnerable to potential viral infections that can remain undetected for many 
years, the use of such feeder cells may have caused contamination of some of the existing cell 
lines.  Although researchers in Singapore have developed a technique to preserve cell lines 
without having to use mouse feeder cells, the damage has already been done to the existing 
cell lines available in the U.S. Bailey, supra note 17, at 149-50.  
38Torrisi, supra note 6, at 159.  It was a Republican-led Congress that in 2005 passed the 
Act in an attempt to reject President Bush’s policy.  Bailey, supra note 17, at 147. 
39Torrisi, supra note 6, at 159.  
40Id. at 159-60.  President Bush’s policy has been attacked by both research advocates and 
anti-research advocates. Research advocates point to the fact that unused embryos continue to 
be discarded at fertilization clinics, arguing that the 2001 distinction is arbitrary.  Anti-
research advocates state that the policy only restricts federal funding of research and says little 
about experimentation funded by private sources; thus, they argue, allowing experimentation 
on any embryos improperly validates embryonic stem cell research.  Bailey, supra note 17, at 
148.  
41The General Assembly of Arkansas made legislative findings in regards to its legislation 
dealing with cord blood donation, explaining that stem cell research has been hampered by the 
controversy over the use of embryonic stem cells, and that umbilical cord blood stem cells 
may be used for scientific research and medical treatment without destroying embryos.  ARK. 
CODE ANN. § 20-8-502 (West 2007).  Furthermore, although studies are not conclusive as to 
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forming stem cells known as hematopoietic stem cells are currently being used to 
treat human diseases.42  These stem cells, found in bone marrow and umbilical cord 
blood,43 are being transplanted to treat more than 75 life-threatening diseases, 
including several types of cancer, bone marrow failure syndromes, blood disorders, 
and immunodeficiencies.44  Patients with these diseases are ill because normal cells 
of the blood system are not functioning correctly.45  The hematopoietic stem cells 
found in cord blood are self-perpetuating and can give rise to mature cell types.46  
When these cells are transplanted into the ill recipient, they begin to generate healthy 
cells and tissues.47  More specifically, after these hematopoietic stem cells are 
transferred into the ill patient, the stem cells, which will reside in the bone marrow of 
                                                          
whether the adult stem cells found in cord blood have as great a potential as embryonic stem 
cells, recent studies have shown that these stem cells are far more useful than previously 
believed.  Torrisi, supra note 6, at 160.  In some studies, cord blood has been shown to 
transdifferentiate to a limited extent into some nonhematopoietic cells, including brain, heart, 
liver, pancreas, bone, and cartilage cells; although purely speculative at this point, these 
studies suggest the possibility that cord blood may serve, in the future, as a source of cells to 
facilitate tissue repair and regeneration.  Kurtzberg, supra note 4, at 2596.  
42NIH, supra note 9.  The American Academy of Pediatrics has found the use of umbilical 
cord blood to be effective in treating certain types of leukemia, lymphomas, aplastic anemia 
and other cytopenias, immune deficiencies, hemoglobinopathies, thalassemia, and sickle cell 
anemia.  American Academy of Pediatrics, Work Group on Cord Blood Banking, Cord Blood 
Banking for Potential Future Transplantation: Subject Review, 104 PEDIATRICS 116, 117 
(1999)[hereinafter A.A.P.].  Furthermore, because umbilical cord blood stem cells are 
removed from the human body after birth, their use does not raise the ethical concerns created 
by the use of embryonic stem cells.  Torrisi, supra note 6, at 160.  
43Sheila R. Kirschenbaum, Banking on Discord: Property Conflicts in the Transplantation 
of Umbilical Cord Stem Cells, 39 ARIZ. L. REV. 1391, 1392 (1997).  About one in every 10,000 
to 15,000 bone marrow cells is thought to be a stem cell. In the blood stream, about one in 
every 100,000 blood cells is a stem cell.  Doctors are able to extract stem cells to be used in 
transplants from peripheral, circulating blood.  The National Institute of Health, Stem Cell 
Information: Hematopoietic Stem Cells, http://stemcells.nih.gov/info/scireport/chapter5.asp 
(last visited November 18, 2007)[hereinafter NIH].   
44Witte, supra note 1, at 277.  The first evidence of the capabilities of blood-forming stem 
cells came from studies in 1945 of people exposed to lethal doses of radiation. In the early 
1960’s scientists began researching and analyzing bone marrow to find out which components 
were responsible for generating blood.  These studies culminated in researchers defining two 
significant characteristics of hematopoietic stem cells, which are their ability to renew 
themselves and produce cells that give rise to all the different types of blood cells.  Since the 
1960’s, research has focused on identifying these cells, which is difficult to do because 
hematopoietic stem cells look and behave like ordinary white blood cells.  NIH, supra note 43.  
45Kirschenbaum, supra note 43, at 1393. 
46Id.  
47Id. at 1393-94.  After chemotherapy or radiation is used to destroy malignant cells in 
patients suffering from cancer, as a result of which the patient’s immune system is severely 
compromised, cord blood stem cells can be used to help restore the immune system.  Stephen 
R. Munzer, The Special Case of Property Rights in Umbilical Cord Blood for Transplantation, 
51 RUTGERS L. REV. 493, 502 (1999).  
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the patient, begin to manufacture mature, disease-free blood and immune systems, 
thus providing the recipient with a means to permanent recovery. 48  
Cord blood stem cell transplants may be performed using blood taken from the 
patient himself, a related family member (usually a sibling), or an unknown donor.49  
Transplants performed with stem cells taken from one’s own cord blood are known 
as autologous cord blood transplants; transplants made by cells donated by a third 
party donor are referred to as allogenic transplants.50  Stem cells used in autologous 
cord blood transplants provide a perfect match to the child from whom it is taken, 
and when used in allogenic transplants, the cells provide a twenty-five percent match 
to siblings.51  
Although bone marrow donations currently provide the most common source of 
hematopoietic stem cells, using cord blood stem cells in transplants has proven to be 
just as effective as bone marrow stem cells52 with added advantages.53  Cord blood 
stem cells are at the intermediate point between embryonic and adult life and have 
high cell proliferation potential.54  Collection of cord blood is painless for both 
mother and infant55 and can be done in a matter of minutes,56 whereas bone marrow 
donation is both painful and time consuming.57  Unlike bone marrow, which can be 
                                                                
48Kirschenbaum, supra note 43, at 1394-96.  See also Jodi K. Fredrickson, Umbilical Cord 
Blood Stem Cells: My Body Makes Them, But Do I Get to Keep Them? Analysis of the FDA 
Proposed Regulations and the Impact on Individual Constitutional Property Rights, 14 J. 
CONTEMP. HEALTH L. & POL’Y. 477, 484 (1998) (explaining that umbilical cord blood is rich 
in stem cells capable of proliferating into the various components of blood, thus serving as a 
viable substitute for a traditional bone marrow transplant).  
49See Witte, supra note 1, at 277 (explaining that the cord blood used in transplants can be 
obtained from the patient himself or from a third-party donor).  See also Kirschenbaum, supra 
note 43, at 1394-95 (stating that the patient himself, an identical twin, or a sibling tend to be 
the closest match to the recipient, and thus the best source of stem cells). 
50Witte, supra note 1, at 277.  See also Fredrickson, supra note 48, at 486 (explaining that 
the distinction between autologous and allogenic transplants is that the stem cells used in 
autologous transplants are banked for use solely by the donor).  
51Orthner, supra note 1, at 206. 
52Kurtzberg, supra note 4, at 2593.  The reported survival rates of cord blood transplant 
recipients are similar to those transplanted with matched bone marrow from unrelated donors, 
despite the fact that the cord blood was usually slightly mismatched.   Id.  
53Witte, supra note 1, at 277.  Bone marrow donation procedure entails anesthetizing the 
donor, puncturing a bone, usually a hipbone, and drawing out the bone marrow cells with a 
syringe.   In addition to harvesting long-term, blood-forming stem cells, other cells present in 
the donated marrow include stromal cells, stromal stem cells, blood progenitor cells, and 
mature and maturing white and red blood cells.  NIH, supra note 43.  
54C.P. McGuckin & N. Forraz, Potential for Access to Embryonic-Like Cells from Human 
Umbilical Cord Blood, 41 CELL PROLIFERATION 31, 33 (2008). 
55Kirschenbaum, supra note 43, at 1397. 
56Kurtzberg, supra note 4, at 2594. 
57Kirschenbaum, supra note 43, at 1397.  See also David A. Suski, Frozen Blood, 
Neonates, and FDA: The Regulation of Placental-Umbilical Cord Blood, 84 VA. L. REV. 715, 
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harvested from a donor of any age, umbilical cord blood is taken from newborns and 
as a result is less likely to contain transmissible infectious diseases, like 
cytomegalovirus and Epstein-Barr virus.58  Cord blood stem cells are also more 
readily available for transplant.59  With a global rate of about 100 million births per 
year, cord blood remains the largest source of available stem cells.60   
In addition, when compared to bone marrow, cord blood stem cells demonstrate 
better tolerance for slight mismatches between donor and recipient, thus decreasing 
the risk of complications.61  The degree to which the donated cord blood stem cells 
match, that is, are molecularly similar to, the recipient cells is measured by human 
leukocyte antigen (“HLA”) typing.62  Due to their immaturity, cord blood stem cells 
are less sensitive to slight HLA mismatches.63  As a result, cord blood is more likely 
to engraft,64 and less likely than bone marrow to cause a complication called graft-
versus-host disease,65 in which donor cells attack host cells and tissue.66  
                                                          
721 (1998) (explaining that one of the drawbacks to use bone marrow rather than umbilical 
cord blood in transplantation is that bone marrow transplants are painful for both the donor 
and recipient).  
58Mitchell S. Cairo & John E. Wagner, Blood: Placental and/or Umbilical Cord Blood: An 
Alternative Source of Hematopoietic Stem Cells for Transplantation, 90 J. AM. SOC’Y 
HEMATOLOGY 4665, 4674 (1997). See also Fredrickson, supra note 48, at 484 (stating that 
umbilical cord blood stem cells are less likely to contain infectious agents than bone marrow 
stem cells taken from an adult donor because the source of cord blood stem cells is an infant 
who is less likely to have been exposed to sensitizers or allergens).  
59Kirschenbaum, supra note 43, at 1397.  See also Munzer, supra note 47, at 503 (stating 
that cord blood is more readily available to unrelated recipients than bone marrow).  Because 
matches are hard to find, most bone marrow recipients wait anywhere from one month to six 
years before finding a matching donor. As a result, many patients deteriorate or die while 
waiting for a match to be found.  This problem is even more pronounced for non-Caucasian 
individuals because they represent a smaller portion of the donor pool and thus have a harder 
time finding a matching bone marrow donor.  Suski, supra note 57, at 721-22.  See also 
A.A.P., supra note 42, at 116 (stating that although the number of patients who receive 
unrelated donor bone marrow transplants continues to increase each year, five percent of 
recipients wait two months for transplantation, fifty percent of recipients wait four months, 
and ninety-five percent wait sixteen months.  Locating a match among racial and ethnic 
minorities is also more difficult because of the limited number of donors.  Because patients 
could die while waiting for donors, umbilical cord blood provides a life-saving alternative.)  
60McGuckin & Forraz, supra note 54, at 33.  
61Frederickson, supra note 48, at 484.  
62Kirchenbaum, supra note 43, at 1394.  
63McGuckin & Forraz, supra note 54, at 33.  
64Munzer, supra note 47, at 503-04.  Engraftment is the process by which the donor’s cells 
are accepted by and proliferate into the recipient’s body.  Engraftment is crucial because it 
helps restore hematopoiesis and the patient’s immune system. Id.  
65Kirschenbaum, supra note 43, at 1394.  See also Munzer, supra note 47, at 504 
(explaining that cord blood transplants may result in a lower incidence and severity of graft-
versus-host disease than do bone marrow transplants, even in cord blood transplants with some 
HLA mismatch between the donor and recipient).  Id.  
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Although hematopoietic stem cells harvested from cord blood have several 
advantages over bone marrow, one disadvantage of cord blood is that doctors are 
only able to extract enough stem cells from the blood for use in transplant for a child; 
rarely can enough stem cells be extracted from umbilical cord blood for use in 
transplant for an adult.67  Furthermore, cord blood can be donated only once, whereas 
a bone marrow donor can produce new marrow and donate again.68  Therefore, while 
bone marrow donors can provide multiple transplants for many different individuals, 
donation of umbilical cord blood is much more restricted in amount.69   
The heightened focus on embryonic stem cells results in a failure to recognize the 
potential therapeutic uses of cord blood stem cells.70  Although there is no conclusive 
data stating that adult stem cells found in cord blood have as great a potential as 
embryonic stem cells, recent studies have shown that these stem cells are far more 
useful than previously believed.71  In some studies, cord blood has been shown to 
“transdifferentiate to a limited extent into nonhematopoietic cells, including those of 
the brain, heart, liver, pancreas, bone, and cartilage.”72  After discovering an 
embryonic-like capability of some umbilical cord blood stem cells to differentiate 
into a greater number of cells than originally thought, some researchers hypothesize 
that some primitive stem cell groups from embryonic development are able to remain 
in cord blood.73  After discovering these cells, which are referred to as cord blood-
derived embryonic-like stem cells, some scientists suggest a potential use of these 
cord blood cells to establish stem cell lines with embryonic properties.74  Although 
purely speculative at this point, these studies suggest the possibility that cord blood 
may serve, in the future, as a source of cells to facilitate tissue repair and 
                                                          
66Kirschenbaum, supra note 43, at 1394.  Graft-versus-host disease does not occur in 
transplants done with cells taken from an identical twin or in autologous transplants.  Id. 
67NIH, supra note 43.  Initially, cord blood transplantation was restricted to use in 
children, usually weighing less than 40 kilograms. Kurtzberg, supra note 4, at 2593.  It was 
believed that the limited number of cells available from a single unit of umbilical cord blood 
was thought to represent only five percent of the optimal dose required for adult 
transplantations.  McGuckin & Forraz, supra note 54, at 34.  More recently, however, use of 
cord blood has been extended to include adults.  Kurtzberg, supra note 4, at 2593.  However, 
the problem has not been completely alleviated; the majority of recipients of cord blood stem 
cell transplants have still been on the small side, weighing less than 70 kilograms.  
Fredrickson, supra note 48, at 485. 
68Munzer, supra note 47, at 504.  
69Id.  
70See also McGuckin & Forraz, supra note 54, at 31 (stating that “all too often media 
attention clouds the reality that there are many types of stem cells” and that, despite the strong 
emphasis placed on embryonic stem cells, adult stem cells found in bone marrow and 
umbilical cord blood are of the types of stem cells with current successful clinical use).   
71Torrisi, supra note 6, at 160.  
72Kurtzberg, supra note 4, at 2596. 
73McGuckin & Forraz, supra note 54, at 34.  
74Id. at 34-37.  
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regeneration in a way previously thought to be possible only with embryonic stem 
cells.75   
III.  UMBILICAL CORD BLOOD STEM CELLS: COLLECTION AND STORAGE 
Collection of cord blood from the placenta is relatively simple and is usually part 
of routine obstetric practice.76  After delivery of the infant, umbilical cord blood, 
which is usually discarded, can be collected from the placenta while it is still in utero 
or after it has been delivered.77  In order to harvest the stem cells, a needle attached 
to a collection bag punctures the umbilical vein and the bag is placed below the 
placenta, allowing the blood to flow from the placenta through the cord and into the 
bag.78  Usually between 70 and 80 cubic centimeters of cord blood is collected; 
however, any amount between 40 and 200 cubic centimeters is sufficient for 
banking.79   After the blood is collected, samples are taken for HLA-typing, cell 
counts, and other testing.80  An anticoagulant and a cryopreservative are then added 
and the sample is stored under liquid nitrogen.81  The cord blood must then be 
received by the collection center within twenty-two hours.82  The entire donation 
procedure, which poses no physical risk to the mother or baby, can be completed in 
about nine or ten minutes.83   
Parents may donate umbilical cord blood to public banks for public use or to 
private banks for use by the donating family.84  Women delivering healthy babies at 
term may donate umbilical cord blood to a public bank, which is then available to the 
public for use.85  Donations to public banks increase the likelihood that a potential 
                                                                
75Kurtzberg, supra note 4, at 2596.  
76Witte, supra note 1, at 276.  
77Fredrickson, supra note 48, at 483, 486.  The timing of umbilical cord clamping after 
delivery of the infant is important to cord blood donation.  Because transplants with greater 
amounts of stem cells tend to be more successful, donations with greater volumes of blood are 
desired.  This could encourage health care personnel to attempt to harvest more cord blood by 
clamping the umbilical cord earlier after birth.  Immediate clamping after birth would increase 
the volume of placental blood for banking; however, if clamping is done too soon after birth, 
the infant may be deprived of a placental blood transfusion, resulting in lower blood volume 
and increased risk for anemia later in life.  Practicing immediate cord clamping as a means to 
increase the volume of cord blood available for banking is unethical  and should be strongly 
discouraged.  A.A.P., supra note 42, at 116-17.  
78Kurtzberg, supra note 4, at 2594.  The average amount of blood collected is between 70 
and 80 cubic centimeters; however, any amount between 40 and 200 cubic centimeters is 
sufficient for banking.  Fredrickson, supra note 48, at 487.  
79Fredrickson, supra note 48, at 487. 
80Id. at 486-87.  
81Id. at 487.  
82Id. 
83Kurtzberg, supra note 4, at 2594. 
84Orthner, supra note 1, at 206. 
85Kurtzberg, supra note 4, at 2595.  
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transplant recipient will find a match from an unrelated donor.86 On the other hand, 
parents who donate to a private bank preserve the umbilical cord blood for sole use 
by their family.  This procedure ensures that, if later in life someone within the 
family needs a stem cell transplant, cells are available.87   
In spite of the high likelihood of match, because it is unlikely that someone 
within the family will actually need the privately banked stem cells, physicians 
recommend public banking, rather than private.88  The risk factors indicating a 
possible need for future stem cell use within a family, thus justifying private 
banking, include a sibling with cancer, a hemoglobinopathy, marrow failure, 
congenital immunodeficiency syndrome, or inborn error of metabolism.89  However, 
only about one in 20,000 families have risk factors for genetic diseases that may 
require a stem cell transplant90 and there is only a one in 10,000 chance that the 
infant donor will later require a transplant.91  Furthermore, while donation to a public 
                                                                
86Orthner, supra note 1, at 206. 
87Kirschenbaum, supra note 43, at 1392.  Concerns about exploitation have arisen in 
response to aggressive advertising done by private cord blood banks.  Advertisements, for 
example, promise “peace of mind and a powerful medicinal resource to treat many severe 
illnesses for your child and loved ones,” and thus play on the fears of new parents wanting to 
provide every advantage for their newborn child.  Advertisements may be inaccurate or 
misleading, referencing rare, yet-to-be-tested applications of cord blood donations.  Kurtzberg, 
supra note 4, at 2595.  See also Fredrickson, supra note 48, at 483 (explaining that premature 
commercialization and solicitation of families provided the impetus for the FDA’s decision to 
regulate cord blood stem cells).  In addressing the problematic nature of these practices, the 
American Academy of Pediatrics points out that families may be vulnerable to emotional 
marketing at the time of birth of a child and may look to their physicians for advice.  The 
Academy encourages cord blood banks, both public and private, to develop recruitment 
practices with an awareness of the possible emotional vulnerability of pregnant women and 
their families and friends, and recommends that efforts be made to minimize the effect of this 
vulnerability on recruitment decisions.  A.A.P., supra note 42, at 116-17.  
88Witte, supra note 1, at 277-78.  Since the establishment of the first umbilical cord blood 
banks, tension between public and private banks has existed.  In Europe, official opinion is for 
public and against private cord blood banking.  Citing the lack of corroboration for any 
therapeutic usefulness of autologous transplants provided by commercial banking, the French 
National Ethics Committee took the position that decision makers should encourage the 
growth and support of public cord blood banks in order to facilitate allogenic transplants.  Italy 
has gone a step further, making commercial cord blood banking illegal.  Jennifer Gunning, 
Umbilical Cord Cell Banking: An Issue of Self-Interest versus Altruism, 26 MED. & L. 769, 
779-80 (2007).  However, in spite of the fact that donors are encouraged to participate in 
public banking, in the United States, private banks are more widely used.  Torrisi, supra note 
6, at 161.  
89Kurtzberg, supra note 4, at 2595.  
90Orthner, supra note 1, at 212.  The vast majority of families who participate in private 
banking do so for future use in treating degenerative diseases or problems related to injuries or 
aging, even though there is no evidence that use of the stem cells will be feasible in such 
circumstances.  Kurtzberg, supra note 4, at 2595.  
91Orthner, supra note 1, at 212.  Estimates regarding the likelihood of children needing 
their own stored cells vary.  The American Academy of Pediatrics explains that the range of 
current estimates is anywhere from 1:1,000 to 1:200,000.  The Academy explains that because 
evidence that children will need their own stem cells for future use is lacking and because 
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bank is usually free of charge, private banking can be quite expensive.92  Private 
banking typically requires an initial storage fee of $1,000-1,500 and a $100 annual 
storage fee.93  As a result, absent conditions that indicate a future need for sibling 
cord blood transplantation, private banking is discouraged and public banking is 
recommended.94  
Different organizations manage and network the different public cord blood 
donations.95 For example, the National Marrow Donor Program (“NMDP”), which is 
the largest public banking network in the United States,96 manages a registry listing 
                                                          
there is limited or no evidence regarding the safety or effectiveness of autologous cord blood 
transplantation in treating certain conditions, it is not recommended that parents store a child’s 
cord blood for future use by that child.  A.A.P., supra note 42, at 116.  
92Id. at 206. 
93Kurtzberg, supra note 4, at 2595.  StemCyte Family cord blood services, a private bank, 
charges an initial $1,925, which covers enrollment, collection, shipping, processing, freezing, 
and the storage fee for the first year.  For each year of storage thereafter, StemCyte charges 
$125, from when the infant turns one year old and continuing until he or she is eighteen.  
Orthner, supra note 1, at 206.  
94A.A.P., supra note 42, at 117.  It has been suggested by some that the United States 
should follow certain European banking services and create dual private and public cord 
banks.  A dual bank, like Europe’s Virgin Health Group, would retain a certain percentage of 
the donated cord blood stem cells for private use, and then designate the remaining cells for 
public use.  This type of banking would expand the opportunity for research of umbilical cord 
blood stem cells because researchers would have access to cells that otherwise would have 
been reserved solely for private use.   Torrisi, supra note 6, at 161-62.  
95As of 2005, there were approximately 14 public cord blood banks in the United States 
and 30 more worldwide.  Kurtzberg, supra note 4, at 2595.  In the UK, a public bank called 
the National Blood Service Cord Bank currently stores over 7,000 cord blood units. In the 
United States, the National Marrow Donor Program manages a tremendous public registry.  
On the global front, the Bone Marrow Donors Worldwide registry collects data from 38 cord 
blood registries from 21 countries and facilitates access to over 200,000 cord blood units 
worldwide, from both public and private banks.  McGuckin & Forraz, supra note 54, at 33.  In 
spite of these voluminous numbers, however, all public banks struggle financially because the 
revenues generated from sales of cord blood units are generally not enough to support the 
bank’s basic operations.  Kurtzberg, supra note 4, at 2595.  
96International Cord Blood Society, Public Cord Banking, http://www.cordblood.org/ 
cord_blood_donations.htm (last visited December 19, 2007).  The NMDP manages a diverse 
registry of more than 7 million bone marrow donors and 70,000 cord blood units. National 
Marrow Donor Program, Providing Hope, Delivering a Cure, http://www.marrow.org/ 
ABOUT/Providing_Hope/index.html (last visited September 20, 2008).  The NMDP connects 
more than 450 centers worldwide, which includes transplant centers, donor centers, 
recruitment groups, cord blood banks, collection centers, laboratories, apheresis centers 
(hospitals that perform peripheral blood stem cell collections) and repositories (centers that 
store samples from donors to enable quick follow-up testing when a donor is identified as a 
potential match), in order to make stem cell transplants possible.  National Marrow Donor 
Program, The NMDP Network of Centers, http://www.marrow.org/ABOUT/Providing_Hope/ 
NMDP_Network/index.html (last visited September 20, 2008).  
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the public banks that are part of the National Marrow Donor Program Network.97  
The registry also lists the cord blood units collected by hospitals participating in the 
NMDP or other public banking networks, thereby making those units available to 
any patient in need of transplant.98  However, only certain hospitals are aligned with 
a public bank and therefore it is not possible to donate cord blood at every hospital.99  
If the hospital participates in cord blood donation, then women interested in donation 
must contact the cord blood bank that works with her hospital to start the donation 
process.100  If the patient’s hospital does not participate in donation, then the only 
other option available to the patient is to find another bank in her area that accepts 
cord blood for public donation.101  Furthermore, the availability of public banks and 
hospitals that collect donations for those public cord banks varies from state to 
state.102  For example, in Ohio only one hospital located in Columbus provides 
donation services.103  
IV. HISTORY OF CORD BLOOD TRANSPLANTS AND THE CURRENT DEMAND FOR 
DONATIONS 
Umbilical cord blood has been used in stem cell transplants for treatment of a 
variety of diseases since the 1980’s.  The first successful transplantation of cord 
blood was performed in Paris in 1988 on a 6-year-old boy from North Carolina.104  
The patient, who was suffering from Fanconi’s Anemia,105 received a transplant of 
umbilical cord blood from his baby sister, fully reconstituting his blood, bone 
marrow, and immune system with the donor cells.106  In 1991, the first public cord 
                                                                
97National Marrow Donor Program, Where to Donate Cord Blood, 
http://www.marrow.org/HELP/Donate_Cord_Blood_Share_Life/How_to_Donate_Cord_Bloo




101Id.  The patient may also be able to donate umbilical cord blood through Cryobanks 
International, which accepts donations from anywhere in the continental United States to be 
listed on the NMDP Registry.  However, Cryobanks International has its own requirements 
and eligibility process, and the interested patient must contact Cryobanks to determine if 
donation would be feasible.  Id.  The patient can also inquire as to whether her hospital accepts 
cord blood donations for research purposes, rather than for use in future stem cell transplants.  
Id.   
102Id.   
103Id.  There truly is a wide range in availability of donation services throughout the 
United States.  For example, in Georgia, Massachusetts, Ohio, and Utah, only one hospital 
participates in cord blood donations, whereas in Florida there are nine hospitals, in Illinois, 48, 
in Missouri, nineteen, in New York, 20, and in New Jersey, 28. Id.  
104Kurtzberg, supra note 4, at 2592.  
105Id.  Classic effects of Fanconi’s Anemia include retarded growth, an extra thumb, only 
one kidney, and hypospadias.  Witte, supra note 1, at 275.  
106Kurtzberg, supra note 4, at 2592.  When the patient’s mother became pregnant a second 
time, doctors discovered that the baby was an identical HLA match to her brother and 
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blood bank in the world was created at the New York Blood Center, and in 1993, the 
first unrelated-donor cord blood transplant was performed on a 3-year-old child with 
leukemia, using a cord blood unit from that bank.107  
In the time between the first unrelated-donor cord blood transplant in 1993, and 
2005, there have been more than 6,000 unrelated-donor transplants performed in 
more than 150 locations around the world.108  In 2003 alone, nearly 3,000 transplants 
were performed.109  This is a significant increase from the nearly 2,000 transplants 
performed in 2000 and the 100 transplants in 1995.110  Although these statistics seem 
to suggest that cord blood donations and transplants are being performed at a high 
rate, the reality is that donations and transplants, as a result of a general lack of 
awareness of the option to donate, occur at a rate far below what is necessary for 
effective use of this technology.111   
V.  CURRENT FEDERAL AND STATE LEGISLATION 
Federal and state legislatures have proposed and enacted legislation to support 
and encourage cord blood donation.  In 2005, Congress recognized the need to 
support and increase umbilical cord blood donation and enacted the Stem Cell 
Therapeutic and Research Act.112  The legislation was enacted to provide “the 
[f]ederal support that is necessary…to more fully realize the potential of cord blood 
as a source material for stem cell transplantation.”113  Congress recognized that the 
inventory of cord blood currently available fell far below the estimated need,114 and 
as a result, passed the legislation, which established a national umbilical cord blood 
program and called for the collection and maintenance of 150,000 new units of cord 
                                                          
unaffected by the disorder. After delivery of the baby girl, the umbilical cord blood was 
preserved, and then 8 months later transplanted into the patient.  Five months after 
transplantation, the patient, who had normal clinical and laboratory results, was discharged.  
Witte, supra note 1, at 275.  Although most scientists and physicians were highly skeptical at 
the time, doubting that a small amount of cord blood contained enough stem cells to 
reconstitute the child’s bone marrow, the treatment was successful, and the child remained 
well and durably engrafted with donor cells for years following the procedure.  Kurtzberg, 
supra note 4, at 2592.  
107Kurtzberg, supra note 4, at 2592. 
108Id. at 2593.  
109Witte, supra note 1, at 278.  
110Id.  
111Much of the legislation dealing with the subject of umbilical cord blood has noted that a 
major goal of the legislation is to rectify the discrepancy between the number of cord blood 
units available and the need for transplants.  See, e.g., S. REP. NO. 109-129, § II (2005). 
112Id.  
113Id.  The legislation was also intended to address the lack of consistent standards for 
donor identification, collection and storage of cord blood, and provide a single information 
system, readily accessible by both patients and providers, designed to facilitate timely 
successful identification of matching transplant material.  Id.  
114Id. 
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blood to be used in transplantation and research.115  Furthermore, Congress 
recognized that in order to increase the number of donations, it would be necessary 
to provide pregnant women with clear information about cord blood donation to help 
them make an informed choice regarding whether to donate.116 
Many states have followed the federal government in addressing the need to 
encourage cord blood donation by proposing or passing their own legislation.117  
California, for example, passed legislation requiring the State Department of Public 
Health to develop information about umbilical cord blood donation that is sufficient 
to allow a pregnant woman to make an informed decision regarding cord blood 
donation.118  However, even though the information is to be made available over the 
internet, there is no provision in the California legislation mandating that health care 
workers provide patients with information.119  Section (d)(1) of the Code states, “[a] 
primary prenatal care provider of a woman who is known to be pregnant may, during 
the first prenatal visit, provide the information…to the pregnant woman” (emphasis 
added); therefore, presumably, the decision to provide the information is at the 
discretion of the health care provider.120  While the legislators in California should be 
commended for their steps taken to support cord blood donation, the legislation falls 
short of what is required.  Legislation must require that information be provided to 
pregnant women. 
Other states have passed or proposed more demanding legislation.  Arizona 
passed legislation, effective January 1, 2007, which states that any health care 
professional that has a patient in her second trimester of pregnancy must inform the 
patient of the option to donate umbilical cord blood.121  More specifically, the health 
care professional must inform the patient of her options related to cord blood stem 
cells, which include discarding the cells, donating the cells to a public bank, storing 
the cells in a private family cord blood bank for use by immediate and extended 
family members, or storing the cells for family use through a family or sibling donor 
                                                                
115H.R. 2520, 109th Cong. (2005).  See also 42 U.S.C.A. § 274k (West 2007) (stating that 
the purpose of the legislation was to increase the number of transplants for recipients suitably 
matched to biologically unrelated donors of bone marrow and cord blood).  
116Orthner, supra note 1, at 208. 
117See Ariz. Rev. Stat. Ann. § 32-3212 (2007); Ark. Code Ann. § 20-8-504 (West 2007); 
Cal. Health & Safety Code § 123371 (West 2007), amended by 2007 Cal. Legis. Serv. Ch. 517 
(S.B. 962) (West); Fla. Stat. Ann. § 381.06015 (West 2007); Ga. Code Ann. § 31-46-3 (West 
2007); 20 Ill. Comp. Stat. Ann. 2310/2310-342 (West 2007); Kan. Stat. Ann. § 65-1249 
(2006); Md. Code Ann., [Health—Gen] § 19-308.7 (West 2007); Mass. Gen. Laws Ann. ch. 
111L § 5 (West 2007); N.M. Stat. Ann. § 24-27-4 (West 2007); N.Y. Pub. Health Law § 4371 
(McKinney 2007); N.D. Cent. Code § 23-16-15 (2007); Tenn. Code Ann. § 68-32-105 (West 
2007); Tex. Health & Safety Code Ann. § 162 (Vernon 2007); Va. Code Ann. § 32.1-69.3 
(West 2007); Wis. Stat. Ann. § 146.343 (West  2007). 
1182007 Cal. Legis. Serv. Ch. 517 (S.B. 962) (West).  
119Id.  
120Id.  
121ARIZ. REV. STAT. ANN. § 32-3212 (2007).  The statute does, however, provide an 
exemption from the obligation to inform the patient about cord blood donation options if the 
information conflicts with the health professional’s bona fide religious beliefs.  Id.  
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banking program that provides free collection, processing, and storage where there is 
medical need.122  Furthermore, the legislation states that if the department of health 
services has issued a pamphlet on the subject of cord blood donation, the health 
professional must provide the patient with that specific pamphlet.123 
The state of Georgia has passed similar legislation requiring that information 
about cord blood donation be provided to pregnant patients.  Section 31-46-3 of the 
Georgia Annotated Code requires health care providers to inform pregnant patients 
of the option to donate postnatal tissue and fluids; this includes umbilical cord 
blood.124  The information must consist of an explanation of public and private 
banking, the medical process involved in collection and storage of donated tissue and 
fluids, the uses of such donated material, the benefits and risks involved in banking 
the material, and the availability and costs of using public and private cord blood 
banks.125  Georgia’s legislation requires the physician to inform the pregnant patient 
“of the full range of options for donation of postnatal tissue and fluids no later than 
30 days from the commencement of the patient’s third trimester of pregnancy or at 
the first consultation between the attending physician or the hospital, whichever is 
later…”126 
Even though these states have taken steps to encourage distribution of 
information, there is no statutory requirement that the opportunity to donate be made 
available to each pregnant patient at that specific health care facility.  Therefore, 
although the legislation has the potential to increase awareness of cord blood 
donation opportunities, because there is no assurance that donation services will be 
made available to each patient, there is no certainty that if the patient, once informed 
of her donation options, wants to donate, she will be able to do so.  As a result, 
although well intentioned, it is unlikely that these pieces of legislation will increase 
donations.   
VI.  OHIO HOUSE BILL 237 
Ohio’s proposed legislation, OH H.B. 237, is similar to the legislation enacted in 
California. OH H.B. 237 requires the state department of health to prepare and 
distribute written materials to health care providers that contain objective 
information about umbilical cord blood banking that is sufficient to allow a pregnant 
                                                                
122Id.  
123Id.  Although the health care professional is required to provide the department of 
health services’ pamphlet, if one has been made available, the statute also states that the health 
care provider meets the notification requirements of the statute by providing the information 
verbally, in writing, or by providing the patient with a publication prepared by the department 
of health services.  Id.  
124GA. CODE ANN. § 31-46-3 (West 2007).  The statute designates the Georgia 
Commission for Saving the Cure as responsible for developing a program to educate pregnant 
patients about public and private banking of postnatal tissue and fluid.  Id.  
125Id.  
126Id.  Like the Arizona statute, Georgia’s statute § 31-46-3 also includes an exemption 
from the obligation for religious reasons, stating that “this subsection shall not be construed to 
require the participation of any physician who objects to the transfusion or transplantation of 
blood on the basis of bona fide religious beliefs.”  Id.  
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woman to make an informed decision regarding whether to donate.127  The legislation 
states that the department of health is to encourage health care professionals to 
provide pregnant women with the written materials before their third trimester of 
pregnancy.128  Like the California legislation, there is no provision within the text 
requiring health care practitioners to provide each pregnant woman with the 
information.   Furthermore, there is no requirement that donation services be 
provided to each pregnant patient at each hospital or health care facility. Without 
those requirements, it is unlikely, if enacted, that this piece of legislation will 
increase donations.  
VII.  ORGAN DONATION LAWS 
In order to understand how the system of organ donation can serve as a model for 
cord blood donation, it is important to review the history of organ donation in the 
United States.  Just as with cord blood donations, after the first successful organ 
transplant in 1954 and the flourishing number of transplant procedures performed 
thereafter, it became evident that organ donation under existing legislation was 
insufficient to satisfy the demand.129  In response, a model law, called the Uniform 
Anatomical Gift Act (“UAGA”) was approved in 1968, and by 1973, it had been 
adopted in some form by all fifty states.130  Through the Act, the legislature sought to 
encourage individuals to become organ donors, specifically providing that any 
person eighteen years of age or older may make a gift, effective upon death, of all or 
any part of his or her body, to be used in transplants.131  Because the act sought to 
                                                                
127H.R. 237, 127th Gen. Assembl., Reg. Sess., (Ohio 2007).  The proposed legislation was 
introduced in May of 2007 and referred to committee in June of 2007.  Id.  
128Id.  OH H.B. 237 also requires that the department of health distribute the materials free 
of charge.   Id. 
129Kurnit, supra note 8, at 410.  It was really not until the early 1960’s that physicians 
began to be truly successful with organ donation.  The development of immunosuppressive 
therapies finally allowed doctors to control organ rejection, thus making successful 
transplantation possible.  Maryellen Liddy, The “New Body Snatchers”: Analyzing the Effect 
of Presumed Consent Organ Donation Laws on Privacy, Autonomy, and Liberty, 28 FORDHAM 
URB. L. J. 815, 821 (2001). 
130Kathleen S. Andersen & Daniel M. Fox, The Impact of Routine Inquiry Laws on Organ 
Donation, 7(5) HEALTH AFF. 65, 67 (1988).  By 1968, forty-two states had legislation 
regulating organ donation; the National Conference of Commissioners on Uniform State Laws 
introduced the UAGA partly in order to deal with the lack of uniformity among the states in 
regard to organ donation law.  By 1972, every state and the District of Columbia had enacted 
some form of the UAGA.  Abena Richards, Don’t Take Your Organs to Heaven…Heaven 
Knows We Need Them Here: Another Look at the Required Response System, 26 N. ILL. U. L. 
REV. 365, 371-72 (2006).  In drafting the UAGA, the National Conference of Commissioners 
sought to reconcile the many different competing interests associated with organ donation.  
These interests included the potential donor’s wishes during his lifetime, the wishes of his 
surviving family, the state’s interest in conducting an autopsy in cases of crime or violence to 
determine the cause of the death, the need for such an autopsy when private legal rights are 
affected by the cause of death, and society’s need for donated organs and tissue for education, 
research, therapy, and transplantation purposes.  Liddy, supra note 129, at 822. 
131Kurnit, supra note 8, at 410.  The UAGA recognized the right of next-of-kin to donate 
organs of individuals who had not expressed an unwillingness to do so, but it required the 
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encourage and protect voluntarism and individual rights, while at the same time 
facilitating and encouraging donation, the UAGA became known as embodying the 
concept of “encouraged voluntarism.”132  
However, it quickly became apparent that the system of encouraged voluntarism 
was insufficient to satisfy the demand for organ donation and that federal action was 
necessary.133  In an attempt to raise public awareness and encourage donation, 
Congress, in 1984, enacted the National Organ Transplant Act (“NOTA”).134  The 
                                                          
explicit authorization of either the deceased or the family. Id. at 411.  The UAGA created a 
priority scheme under which those surviving the decedent would be allowed to donate his or 
her organs.  If there were no available people in the prior class at the time of death, and no 
objection made by the decedent during his life or notice of opposition of someone in the same 
or prior class, then the following people could consent to donation: (1) a spouse, (2) an adult 
son or daughter, (3) either parent, (4) an adult brother or sister, (5) a guardian of the decedent 
at the time of his death, and (6) any other person authorized or under obligation to dispose of 
the body.  The sixth category added an element of presumed consent to the act by allowing 
medical examiners, as persons authorized or under obligation to dispose of the body, to release 
the decedent’s organs and tissues when surviving family members were not available to 
object.  This allowed coroners, in some situations, to harvest the organs without receiving any 
express permission from either the donor (through records) or his surviving family members.  
When the UAGA was modified in 1987, the Conference revised the priority scheme, adding a 
category for grandparents of the decedent (which followed the adult brother or sister category 
and preceded the guardian category) and eliminated the category for any other authorized 
person.  In substitution for the authorized person section, the Conference drafters added a 
section specifically authorizing a medical examiner, coroner, or other official to “release and 
permit the removal of a part from a body within that official’s custody, for transplantation or 
therapy,” provided that the official complies with certain safeguards.  These included 
requirements that an organ procurement facility must first request the body part, the official 
must make a reasonable effort to locate the potential donor’s medical records and inform any 
family members that would fall into the priority scheme, the official must not know of any 
objections by the decedent or priority scheme relatives, and the official must ensure that the 
harvesting does not interfere with autopsy or investigation.  The Conference drafters intended 
for the coroner’s release of organs provision under the revised UAGA be more limited and 
restrictive than the earlier authorized person provision.  Liddy, supra note 129, at 822-25.  
Some states that have adopted the UAGA have modified the priority schemes to include health 
care agents, friends, and domestic partners.  Several states have chosen not to adopt the 
coroner release provision; thus in those states, coroners are not able to remove organs without 
a record of the decedent’s consent or family approval.  Id. at 827. 
132Kurnit, supra note 8, at 411.  There are two primary methods under the UAGA for 
making an anatomical gift.  One way is by will and the other is by signing a document, like a 
drivers’ license or identification card.  The latter method requires that the donor sign the 
document in the presence of two witnesses, who are also required to sign the document.  
Richards, supra note 130, at 372.  
133Kurnit, supra note 8, at 411.  See generally Charles J. Dougherty, Commentary: A 
Proposal for Ethical Organ Donation, 5(3) HEALTH AFF. 105 (1986) (explaining that the 
“voluntary opt in” system for organ donation was inadequate to supply all the organs needed 
for transplant, even though transplantable organs existed).  
134Kurnit, supra note 8, at 412.  Congress also enacted the National Organ Transplant Act 
as an attempt to eliminate the black market for organs.  In order to reach this goal and promote 
altruistic donations, NOTA criminalized the sale or purchase of organs, imposing a sentence 
of up to five years in prison or a $50,000 fine for violation.  Richards, supra note 130, at 373. 
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Act established a comprehensive organ procurement and transplant network and 
encouraged state legislatures to adopt routine inquiry legislation, which would 
require hospitals to inform family members of patients of the option to donate.135  In 
1986 Congress passed the Omnibus Budget Reconciliation Act (“OBRA”) and 
adopted a system of required request, which no longer simply encouraged, but 
instead required all hospitals to develop required request protocols.136  
Although often generalized under the term “required request,” there are actually 
two different approaches to organ donation.  “Routine inquiry” requires hospitals to 
inform family members of the option to donate, whereas “required request” requires 
hospitals to expressly ask the family to consent to donation.137  Although OBRA 
superseded state law and required all states to adopt routine inquiry protocols at a 
minimum, the Act did not prevent states from adopting the stricter system of 
required request.138  As a result, great variation exists among the states as to the 
requirements placed upon hospitals and health care workers.139  Some states, like 
California, operate under the federally mandated system of routine inquiry, requiring 
hospital staff to inform the family of the option to participate in organ donation.140  
Other states, like Oregon and New York, have enacted the more demanding required 
request laws.141  Eighteen states have adopted routine inquiry legislation and twenty-
six states and the District of Columbia have passed some version of required request 
laws.142   
VIII.  PROPOSED OHIO LEGISLATION: DISTRIBUTION OF INFORMATION AND 
DONATION SERVICES PROVIDED TO EVERY PREGNANT PATIENT 
Ohio’s proposed legislation is insufficient.  Because Ohio’s legislation fails to 
mandate that information regarding cord blood donation be provided to all pregnant 
women, and will not realistically increase donation, Ohio legislators should discard 
OH H.B. 237 and adopt new legislation.  Better legislation for Ohio would require 
that the state health department compile information regarding umbilical cord blood 
sufficient to allow a pregnant woman to make an informed decision about donation.  
More specifically, the information should describe donation opportunities, the effects 
and uses of cord blood in transplants, and public and private banking.  The 
legislation should require not only that the information be made available via the 
internet, but also to every hospital, clinic, physician, nurse, midwife, or other health 
care provider that has prenatal patients.  Most importantly, using required request 
                                                                
135Kurnit, supra note 8, at 412-13. 
136Andersen & Fox, supra note 130, at 72.  Giving greater teeth to OBRA, the Health Care 
Financing Administration proposed a rule, effective 1988, which required hospitals to comply 
with the 1986 OBRA regulations, and thus comply with routine inquiry laws, in order to retain 
their eligibility for Medicare and Medicaid reimbursement.  Kurnit, supra note 8, at 417. 
137Kurnit, supra note 8, at 412. 
138Id. at 417.  
139Id. at 413. 
140Id. at 414.  
141Id.  
142Andersen & Fox, supra note 130, at 69.  
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organ donation laws as its basis, the legislation should require that all health care 
providers provide their pregnant patients with information about cord blood donation 
opportunities,143 and that health care facilities align with cord blood banks, making 
donation services available at each facility to every pregnant patient.  
There are arguments for and against the forced distribution of information by 
health care providers.  Those who advocate for forced distribution of information 
recognize that the nation is suffering from donation shortages and believe that 
requiring that information be distributed to all maternity patients will increase cord 
blood donations.144  As originally introduced, the California legislation included a 
mandate requiring prenatal workers to give information on cord blood donation and 
banking to all expectant mothers.145  Those who supported the provision requiring 
distribution of information to each pregnant patient recognized that one goal of the 
legislation was to allow expectant parents to make an appropriate, informed choice 
about whether to donate and how the blood should be stored.146  Relying on estimates 
by the Institute of Medicine that cord blood could help treat 11,700 Americans a year 
suffering from different diseases, proponents of the original mandate sought to 
increase the number of cord blood donations by ensuring that every pregnant woman 
is made aware of the opportunity to donate.147  Unless it is certain that each patient is 
provided with information, the advocates argued, patients will not be given the 
opportunity to make a truly informed decision, and donations will not increase.148 
Pregnant women, as a group, recognize that a lack of adequate information about 
cord blood donation results in missed donation opportunities.  A 2001 Canadian 
study showed that of the 443 out of 650 pregnant women who responded, seventy 
percent rated their knowledge about cord blood banking as poor or very poor.149  
                                                                
143The majority of health care providers and blood bank personnel believe that consent to 
cord blood donation should be obtained earlier in the pregnancy.  Kurtzberg, supra note 4, at 
2594.  Consent should not be obtained from a patient already in active labor or in other 
circumstances where her ability to calmly and rationally make decisions is compromised.  Id.  
However, because many women in labor enter the hospital interested in cord blood donation 
without having given prior consent, some health care centers allow women to sign a “mini” 
consent form, allowing collection of cord blood, and then meet with her after delivery to 
further educate her about cord blood donation and banking and to obtain fully informed 
consent.  Id. at 2595.  Because all cells collected for blood banking need to be tested for 
infectious and hereditary diseases before storage, part of the informed consent process must 
also address the issue of what is being tested and how the parents will be informed of 
abnormal test results.  A.A.P., supra note 42, at 117.  The possibility of abnormal test results 
strengthens the demand that parental consent must be obtained before collection of cord blood.  
Id.  The ideal time for obtaining consent is during a prenatal visit, well in advance of the onset 
of labor.  Id.  
144See CA B. An., S.B. 1555, Sen., 8/24/2006.  
145Orthner, supra note 1, at 214.   
146CA B. An., S. B. 1555, Sen. 8/24/2006. 
147Id. 
148See CA B. An., S. B. 1555, Sen. 8/24/2006. 
149Conrad V. Fernandez et al., Knowledge and Attitudes of Pregnant Women with Regard 
to Collection, Testing, and Banking of Cord Blood Stem Cells, CAN. MED. ASS’N. J. 695, 696 
(2003).  Interestingly, about a quarter of the respondents overestimated the risk of a child 
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Most of these women (sixty-eight percent) felt that physicians should convey 
information about cord blood donation opportunities to their pregnant patients,150 and 
most of the women responded that, had they been properly informed, they would 
have donated to a public bank.151  As demonstrated by this study, women who are 
informed of the opportunity to donate cord blood generally wish to participate in 
donation; however, donation opportunities are missed because patients are unaware 
of the option to help others by donating cord blood.  Thus, ensuring that all pregnant 
women are equipped with adequate information will result in an increased number of 
completed donations. 
Arguments against forced distribution of information about cord blood donation 
are minor and insubstantial.  The most significant opposition to the forced 
distribution portion of the California legislation came from physicians, who argued 
that patients would become overwhelmed with information and that physicians 
would become overburdened as a result of all the regulations to which they must 
conform.152  Though this concern may be warranted, the harm that would occur as a 
result of the failure to convey the information would significantly outweigh any 
irritation or burden experienced by the patient or physician as a result of being forced 
to receive or convey more information.  If the inventory of cord blood available for 
transplant continues to fall below the estimated need, individuals suffering from 
devastating diseases will be without adequate treatment and potential cures; certainly 
that devastating result outweighs any minor inconvenience or burden on physicians 
to convey, or patients to receive, more information than already required. 
The true strength of the argument that legislation must contain a provision 
requiring distribution of information to every maternity patient rests in the use of 
current organ donation law as a basis and model for such a requirement.  Like cord 
blood donation, the system of organ donation originally relied on individuals to 
inform themselves of donation options and procedures and express a desire to 
donate.153  Under that system, for donation to occur, the burden was placed on the 
                                                          
needing a bone marrow transplant before his or her tenth birthday. (The current risk is between 
1 in 200,000 and 1 in 10,000.)  Id.  This data may help demonstrate the existing 
misconceptions about the likelihood of future need for stem cells by the donor’s own family.  
Those misconceptions, as a result, may tend to motivate some families to participate in private 
banking even when they lack the genetic factors that indicate a possible future need.  See 
Torrisi, supra note 6, at 161 (stating that private banks are more widely used in the United 
States than are public banks).  
150Fernandez, supra note 149, at 696.  The women wanted to receive information about 
cord blood donation and banking either directly from a health care professional (sixty-six 
percent), or in a prenatal class (seventy percent).  Most of the respondents thought that 
pregnant patients should be asked about umbilical cord blood banking before 30 weeks of 
pregnancy.  Id.  
151Id. at 697.  The two main reasons why the women would donate to a public, rather than 
private, bank were simple altruism and the expense associated with private banking.  Id.  
152Orthner, supra note 1, at 214.  In opposing the California legislation, Kaiser Permanente 
wrote that it believed the legislation constituted an “unwarranted mandate on clinical 
practice.”  Furthermore, Kaiser stated that the value of cord blood banking as a preventative 
measure had yet to be proven and also cited concerns regarding physician liability.  CA B. 
An., S. B. 1555, Sen. 8/24/2006.   
153See Kurnit, supra note 8, at 411. 
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decedent, who had to have expressed desire to donate during his or her lifetime, or 
on his family, who had to consent at the time of death;154 there was no requirement 
on health care workers to provide information or access to donation services.155  
Although the system of encouraged voluntarism sought to eliminate the need to rely 
on purely voluntary action by a potential donor during his lifetime, in practice 
physicians rarely proceeded with the removal absent familial consent.156  As a result, 
even if the deceased had expressly agreed to donate during his or her life, if, at his or 
her death, the family objected to organ donation, it was unlikely that the physician 
would proceed with donation, thus adding a further barrier to organ donation.157  
In the parallel system of cord blood donation,  there is no requirement that health 
care providers distribute information to prenatal patients unless the individual state 
has legislatively enacted such a provision.158  In order to ensure that donations will 
occur when the patient desires, she must already possess knowledge of donation 
options and must express these desires to her health care worker.  In both systems, 
heavy burdens are placed on the individual wishing to donate and it is unlikely, 
based on the nature of those burdens, that donations will occur.  
The insufficient laws of both the encouraged voluntarism system of organ 
donation and the current system in cord blood donation have led to significant 
discrepancies between the amount of donations performed and the actual need.  
Within the encouraged voluntarism system of organ donation, even in situations 
where family members of the potential donor were willing to donate, transplantable 
organs were often wasted because there was no request made for donation.159  
Similarly, when an expecting mother, who would normally be willing to donate her 
child’s umbilical cord blood, is not informed of her option to donate to a bank, the 
opportunity to donate is missed.160  Because donation does not occur, the valuable 
umbilical cord blood is discarded, thereby diminishing the number of potential 
transplants.  In order to alleviate this problem, organ donation law changed, adopting 
the system of routine inquiry; the system of cord blood donation, encountering 
similar problems, should change in similar fashion, adopting requirements of forced 
distribution of information. 
                                                                
154Id. at 410.  
155It was not until 1986, when Congress passed the Omnibus Budget Reconciliation Act, 
requiring hospitals and other health care facilities to develop routine inquiry protocols, that 
hospital workers were specifically required to inform surviving family members of the option 
to donate their loved one’s tissues and organs.  Andersen & Fox, supra note 130, at 72. 
156Kurnit, supra note 8, at 411. 
157Id.  This facet of encouraged voluntarism helps demonstrate some of the limitations of 
the system and the manner in which the system eventually proved insufficient to supply the 
number of organs needed for transplants.  
158The federal legislation encourages cord blood donation but does not require that 
information regarding donation be provided to pregnant women.  Thus, it is up to the state to 
mandate such a requirement.  42 U.S.C.A. § 274k (West 2007). 
159Richards, supra note 130, at 376. 
160See Fernandez, supra note 149, at 697. 
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Although the results of the transition to a system of required request in organ 
donation law is far from clear or conclusive, several states experienced an increase in 
donations shortly after adopting required request protocols.  This would suggest that 
a similar change in cord blood donation law could yield similar results.  For 
example, one year after passing its required request laws, New York experienced an 
increase in heart donations by 94 percent, liver donations by 96 percent, kidney 
donations by 23 percent, and eye donations by 58 percent.161  Following 
implementation of required request laws, the state of Oregon experienced a 20-25 
percent increase in bone and skin donations and a 50 percent increase in eye 
donations.162  
There are overwhelming similarities between the systems of organ donation and 
umbilical cord blood donation.  As a result, it is likely that adopting legislation that 
requires distribution of information and availability of donation services to patients 
in a manner similar to the way family members are informed of donation 
opportunities through required request will cause a similar increase in cord blood 
donations.  
Although other systems, including routine inquiry and presumed consent, exist as 
options for current organ donation law, the system of required request best serves as 
a model for a more adequate cord blood donation law.  Under a system of routine 
inquiry, health care providers are required to simply inform the family of its 
opportunity to donate organs.163  Like the system of required request, routine inquiry 
is an “opt in” system.164  Either the donor or surviving family must authorize 
donation; consent is not presumed.165  Although similar to required request, under a 
system of routine inquiry there is no requirement that the family be specifically 
asked to consent to organ donation.166  
Since the system of routing inquiry would not ensure that each patient would be 
given the opportunity to donate, the system is insufficient as a model for cord blood 
donation.  Routine inquiry, which requires that hospital personnel inform individuals 
of the opportunity to donate, would ensure that patients are aware of cord blood 
donation, but would not ensure that each patient have the opportunity, at each health 
care facility, to donate if she desires to do so.  Because legislation that ensures 
distribution of information to each patient but does not provide for donation services 
at each health care institution will not adequately increase cord blood donations, 
legislation modeled after routine inquiry organ donation laws would be insufficient. 
On the other hand, under a system of presumed consent, a person is presumed, 
upon death, to be a donor, unless he or she expressed opposition to donation during 
his or her life.167   These systems are known as “opt out” systems because in order to 
                                                                
161Andersen & Fox, supra note 130, at 68-69, 75.  
162Id.  
163Kurnit, supra note 8, at 412. 
164Id. at 418.  
165Id.  
166See Id. at 412.  
167Richards, supra note 130, at 378.  In a pure system of presumed consent organ 
donation, only the decedent can opt-out of the system during his lifetime; the wishes of the 
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prevent donation, potential donors or their families must make an expression of 
dissent.168  There are two versions of presumed consent systems used by certain 
states within the U.S.169  A softer version requires a search for next of kin of the 
deceased, whereas the strict system, first introduced in Maryland, does not.170  The 
Maryland Estates and Trust Code provides that a medical examiner is permitted to 
remove the deceased’s organs as long as the medical examiner is not aware of 
objection made by the next of kin or religious objection made by the decedent before 
death.171  The medical examiner is not required to search for an objection and may 
remove the organs as long as he is not aware of any such objections.172  
Although twenty-eight states have adopted presumed consent systems, only nine 
states actively use the laws.173  At least twenty-five nations around the world have 
                                                          
surviving family are not sought nor are they an appropriate basis for the hospital to refrain 
from harvesting the potential donor’s organs.  In less strict systems of presumed consent, 
family members may object to donation, but their wishes will not be actively sought out.  
However, in these less strict versions of presumed consent, health care workers may not 
proceed with removal if they are aware of an objection by the decedent or the surviving family 
members.  Kurnit, supra note 8, at 419.  Furthermore, in some presumed consent systems, 
people may be automatically exempted on the basis of religion.  Richards, supra note 130, at 
378.  
168Kurnit, supra note 8, at 418.  Presumed consent systems are based on the belief that 
while most people wish to donate their organs, they are reluctant to address issues regarding 
death and organ donation while they are still healthy.  Thus a system is required that allows 
the state to act upon this silent consensus and remove organs without express permission, and, 
as a result, increase the number of organs available for donation.  Liddy, supra note 129, at 
819.  Furthermore, while a presumed consent system requires popular support, it also requires 
a well-educated and motivated public.  Because individuals must expressly state their refusal 
to donate while still legally competent, if the public is uneducated about the system, then 
organs will be recovered based upon people’s ignorance, rather than their true desires.  In that 
situation, the underlying support for the system breaks down, and potential donors are not 
provided adequate protection.  Consequently, having an effective presumed consent system 
requires that mechanisms for recording and reviewing opt-outs or dissents, like a centralized 
data bank or registry, be firmly in place.  Id. at 819-20. 




173Id.  Some states have modified their organ donation laws to deal with the extent to 
which a coroner may, upon the decedent’s death, remove certain body parts or tissues.  These 
modifications of organ donation law are known as coroner release statutes.  Delaware, Florida, 
Georgia, Kentucky, Maryland, Massachusetts, Ohio, and Pennsylvania have adopted coroner 
release statutes that allow coroners to remove only the corneas or eyes from decedents based 
on presumed consent.  Mississippi, on the other hand, allows coroners to harvest the 
decedent’s corneas, pituitary glands, and other tissues.  These statutes have raised 
constitutional concerns about property interests in a dead body, giving rise to a number of 
lawsuits.  In Georgia Lions Eye Bank, Inc. v. Lavant, 335 S.E.2d 127 (Ga. 1985), the Supreme 
Court of Georgia addressed the ramifications of Georgia’s coroner release statute when the 
parents of an infant whose corneal tissue was removed during an autopsy filed suit.  The 
parents were not notified of the removal and thus not given the chance to object to the 
procedure; however, the court upheld the statute, holding that removal of the corneal tissue did 
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adopted presumed consent, demonstrating the system’s popularity on the 
international level.174  In order to alleviate a growing shortage of kidneys for 
transplantation, France adopted a system of presumed consent in 1976.175  In June of 
1986 Belgium passed a presumed consent law which was implemented in February 
1987.176  In 1987 Singapore became the first Asian country to enact presumed 
consent legislation.177  Austria operates under a pure system of presumed consent, 
refusing surviving family members the opportunity to object to donation of the 
deceased’s organs.178  After Austria passed its presumed consent law in 1982, the 
donation rate quadrupled and by 1990 the number of performed kidney transplants 
was almost equal to those on the waiting list.179  Belgium also experienced donation 
increases after changing to a system of presumed consent.180  
Presumed consent laws raise ethical concerns within organ donation alone, and 
would raise similar concerns in the system of cord blood donation; this makes it an 
inappropriate model for proposed legislation.  Because in some religions, most 
prominently in Islam, the process of organ donation is either restricted or banned 
completely, a system that presumes that the deceased wished to participate in organ 
                                                          
not violate the parents’ due process rights, because the quasi-property right of survivors’ 
interest in a decedent’s body does not rise to the level of constitutional protection.  However, a 
contrary conclusion was reached in Brotherton v. Cleveland, 173 F.3d 552 (6th Cir. 1999).  In 
Brotherton, the surviving wife filed suit after her husband’s corneas were removed, as 
permitted by Ohio’s limited coroner release statute, during an autopsy.   The wife had refused 
to donate her husband’s organs when he was pronounced dead; however, the coroner’s office 
was not informed of the wife’s objection, and proceeded with the removal.  The court 
recognized that surviving family members have a substantial interest in the decedent’s body, 
and that those property rights rise to the level of a legitimate claim of entitlement under federal 
law.  The court found for the wife, holding that the Due Process Clause protected her property 
interest in her dead husband’s corneas.  Liddy, supra note 129, at 828-31. 
174Richards, supra note 130, at 388. 
175Kurnit, supra note 8, at 421. 
176Id. at 422.  Belgium established a registry for recording dissents within the presumed 
consent system, allowing people to fill out an objection to donation at any local town hall.  
The objections are then registered in a centralized database available only to transplant 
officials.  Physicians, however, are encouraged to discuss organ donation with families, in 
spite of the registry, and are not compelled to harvest any organs if they are uncomfortable 
doing so.   Regardless of this fact, however, the transition in Belgium to presumed consent is 
credited with increasing organ donation by fifty-five percent within five years, in spite of the 
fact that traffic fatalities, a major source of donated organs, decreased over the same time 
period.  Because only two percent of Belgians have registered dissents, supporters of 
presumed consent infer near-unanimous support for the system within the country.  Liddy, 
supra note 129, at 820-21. 
177Kurnit, supra note 8, at 424. 
178Id. at 423. 
179BBC Health, Should the UK Change to an Opt-Out System?, http://www.bbc.co.uk/ 
health/donation/factfilesod_comparisons.shtml (last visited October 27, 2007).  
180Id. Other countries that have adopted presumed consent organ donation laws include 
Italy, Norway, Sweden, and Switzerland.  Liddy, supra note 129, at 820.   
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donation may violate the First Amendment religious freedom of some individuals.181  
A presumed consent system may violate the Fifth Amendment, which prohibits 
governmental takings of private property without just compensation, if organs are 
considered property.182  If defined as property, removal of organs from the deceased 
could require the state to provide the family with compensation for donation.183  
Although presumed consent systems, on the international level, have encountered 
some degree of success in diminishing organ shortages,184 because of the ethical 
concerns that arise in presuming one’s consent to organ donation, and because issues 
regarding consent already exist in cord blood banking, such a system should not be 
applied to cord blood donation law.185  While a minority of banks collect umbilical 
cord blood without the mother’s permission and only ask for consent to keep the 
cord blood if the procedure was successful, the vast majority of banks operate under 
the policy that consent should be obtained prior to collection.186  The American 
Academy of Pediatrics supports this position, having expressly rejected the use of a 
system of presumed consent in cord blood donation, stating that “[t]he practice of 
collecting cord blood first and obtaining permission afterward is considered 
unethical and should be discouraged.”187 
Despite the ethical and constitutional concerns raised by presumed consent, the 
system is gaining more international support.  A BBC poll conducted in May 2005 
showed that public opinion in the UK regarding presumed consent was changing.188  
In 2005, sixty-one percent of those questioned supported a change in UK organ 
donation law to an opt out system, which was a substantial increase compared with 
the twenty-six percent supporting the change in 1999.189  Those supporting the 
                                                                
181Richards, supra note 130, at 393.  
182Id. at 395.  
183Id.  
184Kurnit, supra note 8, at 442-47.  Some countries, however, have not had success with 
presumed consent organ donation laws.  For example, in February of 1997, the Brazilian 
government adopted a presumed consent system, but abolished it only a year later.  The 
government cited widespread public fear and criticism as the basis for the abolishment.  Liddy, 
supra note 129, at 821. 
185The system of presumed consent has not been nationally adopted in the United States as 
an acceptable system for organ donation law, thus making it an unlikely model for cord blood 
donation law.   See Richards, supra note 130, at 392.  
186Kurtzberg, supra note 4, at 2594.  
187A.A.P., supra note 42, at 118.  See also Cairo & Wagner, supra note 58, at 4673 
(stating that consent should not be obtained when the patient is in active labor or immediately 
after delivery).  
188BBC Health, supra note 179.  When the British Medical Association announced in 1999 
that it intended to change its longstanding policy against presumed consent, there was a 
significant lack of public support.  Intense public debate resulted, with critics labeling the 
proposed system as one allowing “body snatching” which would violate the human rights and 
dignity of the people.  As a result, the government eventually rejected the proposal. Liddy, 
supra note 129, at 821. 
189BBC Health, supra note 179.  
2008] THE NEGLECT OF THE UMBILICAL CORD: OHIO’S FAILURE 165 
change are perhaps responding to the failure of the current opt in system.   While 
nearly ninety percent of the UK population say they would be willing to donate their 
organs after death, only about twenty percent of people have actually put their names 
on the NHS Organ Donor Register.190  The British Medical Association, along with 
certain patient groups, transplant surgeons, and the Liberal Democrat party support 
such a change in the law.191   However, because of the concerns regarding 
constitutional violations and consent issues, presumed consent should not be used as 
a model for cord blood donation law.  
Although the systems of routine inquiry and presumed consent contain 
significant elements conducive to increasing the number of completed donations, it is 
the system of required request that can serve as the most appropriate model for cord 
blood donation law.  By rejecting a system of routine inquiry, and instead requiring 
that health care providers not only inform patients of the opportunity to donate but 
also expressly ask them to consent to donation, which could be performed at that 
specific hospital, it becomes much more likely that donations will increase.  At the 
same time, by rejecting a system of presumed consent, and requiring that consent to 
donation be obtained prior to the harvesting of the blood, it is ensured that cord 
blood donations will be performed ethically and with respect for both the infant and 
maternal donors.   
IX.  CONCLUSION 
Because of the significant therapeutic potential associated with embryonic stem 
cells, federal funding of embryonic stem cell research generates great controversy 
and attention.  However, in focusing solely on human embryos as a source of stem 
cells, the public largely ignores the significance of hematopoietic stems cells found 
in the umbilical cord blood of newly delivered infants.  Although umbilical cord 
blood stem cells are currently being used to treat and cure a variety of diseases, a 
lack of awareness about cord blood donation results in many missed donation 
opportunities.  Although legislation has been proposed or adopted by the federal 
government and various state governments, including Ohio, as a means to promote 
and encourage cord blood donation, it is unlikely that such legislation will be 
successful in increasing the number of donations performed because it does not 
ensure that all pregnant women are informed.  More adequate legislation, modeled 
after the required request system of organ donation law, should include a provision 
requiring that health care providers provide information and donation services to 
each pregnant patient.  Legislation will have the potential to increase the number of 
donations performed only by ensuring that pregnant women are aware of their 
options and have donation services available to them.  
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